arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

LABCORP HOLDINGS INC.

LH
$319.08 ▲ +2.49 (+0.79%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
71 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Neutral
auto_awesome

Analytical Summary

LABCORP HOLDINGS INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $26.3B
Dividend Yield 0.23%
Revenue Growth 5.8%
Op. Margin 10.8%
ROIC 2.1%
FCF / Share $0.86
Trailing P/E 94.7x
Price / Book 3.0x
FCF Yield 0.3%
Debt / Equity 0.67
info Valuation on last close. End-of-day price, Aug 7, 2026.

71-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.54B
↑ +5.8%
Net Income Profit after all expenses
$277.80M
↑ +30.5%
Operating Margin Operating profit as % of sales
10.8%
↑ +41.4% 56th
FCF / Share Free cash flow per share
$0.86
↓ -74.6%
Long-Term Debt Long-term obligations
$5.83B
↑ +14.7%

Health Breakdown

Profitability
56
Returns
68
Financial Health
61
Cash Quality
78

Dividend History

Dividend / share · sourced from SEC filings
$2.88 Latest / share
+0.0% YoY
+0.0% 3-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 71 quarters